MabezaG.F., MoyoV.M., ThumaP.E., BiembaG., ParryD., KhumaloH.Predictors of severity of illness on presentation in children with cerebral malaria.Ann Trop Med Parasitol1995; 89(3): 221–8.
2.
GrauG.E., Tacchini-CottierF., VesinC., MilonG., LouJ.N., PiguetP.F.TNF-induced microvascular pathology: Active role for platelets and importance of the LFA-1/ICAM-1 interaction.Eur Cytokine Netw1993; 4(6): 415–19.
3.
HeimM.U., MezgerJ., ScheurlenC., TwardzikL., WilmannsW.Austauschtransfusion und (oder) plasma-pherese: Wirksame Massnahmen bei der schweren Malaria tropica?Dtsch Med Wochenschr1988; 113(23): 941–4.
4.
Di PerryG., Di PerryI.G., MonteiroG.B., BonoraS., HennigC., CassatellaM.Pentoxyfylline as a supportive agent in the treatment of cerebral malaria in children.J Infect Dis1995; 171(5): 1317–22.
5.
MolyneuxM.B., TaylorT.E., WirimaJ.J., BorgsteinA.Clinical features and prognostic indicators in paediatric cerebral malaria: A study of 131 comatose Malawian children.Q J Med1989; 71: 441–59.
6.
AdeyemiE.O., Abdul-ShakurA.Comparison of maternal and cord blood polymorphonuclear leukocyte elastase levels.J Perinat Med1998; 26: 89–93.
7.
CortiA., GasparriA., SacchiA., CurnisF., SangregorioR., ColomboB.Tumor targeting with biotinylated tumor necrosis factor alpha: Structure-activity relationships and mechanism of action on avidin pretargeted tumor cells.Cancer Res1998; 58(17): 3866–72.
